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Evolutionary change in gene expression is generally considered to
be a major driver of phenotypic differences between species. We
investigated innate immunediversificationbyanalyzing interspecies
differences in the transcriptional responses of primary human and
mouse macrophages to the Toll-like receptor (TLR)–4 agonist lipo-
polysaccharide (LPS). By using a custom platform permitting cross-
species interrogation coupled with deep sequencing of mRNA 5′
ends, we identified extensive divergence in LPS-regulated ortholo-
gous gene expression between humans and mice (24% of ortho-
logues were identified as “divergently regulated”). We further
demonstrate concordant regulation of human-specific LPS target
genes in primary pig macrophages. Divergently regulated ortho-
logues were enriched for genes encoding cellular “inputs” such as
cell surface receptors (e.g., TLR6, IL-7Rα) and functional “outputs”
such as inflammatory cytokines/chemokines (e.g., CCL20, CXCL13).
Conversely, intracellular signaling components linking inputs to out-
puts were typically concordantly regulated. Functional consequen-
ces of divergent gene regulation were confirmed by showing LPS
pretreatment boosts subsequent TLR6 responses in mouse but not
human macrophages, in keeping with mouse-specific TLR6 induc-
tion. Divergently regulated genes were associated with a large dy-
namic range of gene expression, and specific promoter architectural
features (TATA box enrichment, CpG island depletion). Surprisingly,
regulatory divergence was also associated with enhanced interspe-
cies promoter conservation. Thus, the genes controlled by complex,
highly conserved promoters that facilitate dynamic regulation are
also the most susceptible to evolutionary change.
evolution | inflammation | innate immunity | pattern-recognition
receptor | transcriptional regulation
Rodents are widely used as models for humans in experimentalpathology. The assumption that mice provide a reliable model
for understanding and treating human disease is a particular
concern for immunological studies, as humans and mice diverged
65 to 75 Mya (1), and pathogens evolve quickly and exert strong
pressure on the immune system to coevolve. Accordingly, many
aspects of innate and acquired immunity are different between
mouse and human (reviewed in ref. 2). High-profile commen-
taries have highlighted limitations of mice for immunological
studies and emphasized the urgent need to identify critical points
of divergence between the species (3, 4).
Macrophages and other cells of the innate immune system
recognize distinct microbial products through families of pattern
recognition receptors such as the Toll-like receptors (TLRs) (5).
Although the TLR family exhibits divergence in expression, se-
quence, and gene number among species, the basic biology and
downstream signaling is generally thought to be conserved. The
most widely studied pattern recognition receptor is TLR4, which
recognizes bacterial lipopolysaccharide (LPS) from Gram-nega-
tive bacteria, as well as several host-derived danger signals. TLR4
is essential for host resistance to a range of bacterial infections, but
dysregulated responses through this receptor lead to systemic in-
flammation (e.g., septic shock). Some species differences in the
transcriptional response to inflammatory stimuli such as LPS are
already appreciated. For example, the inducible nitric oxide syn-
thase (iNOS) gene, the product of which generates the antimi-
crobial agent nitric oxide, is robustly induced by IFN-γ and LPS
in macrophages from mice, but not humans (6) or several other
mammalian species (7). Conversely, the gene encoding the anti-
microbial peptide cathelicidin is TLR-inducible via a vitamin D-
dependent pathway in human but not mouse macrophages (8).
Moreover, mice are relatively resistant to LPS-mediated toxicity
(9), and many therapeutic agents that reduce inflammation and
mortality in mouse septic shock models show no benefit clinically
(10) or even increase mortality (e.g., nitric oxide antagonists) (11).
Multiple mechanisms can contribute to phenotypic differences
between species. These include the evolution of nonorthologous
genes, functional evolution of orthologous genes (e.g., changes in
amino acid sequence affecting function), and evolution in tran-
scriptional regulation of orthologous genes. Extensive gene ex-
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pression divergence between even closely related species clearly
exists (12–18), but our understanding of how gene regulation
evolves, and the impact of this on phenotypic diversity is limited.
A number of mechanisms could contribute to expression di-
vergence between species, including divergence in cis (e.g., pro-
moter/enhancer sequence change) or in trans (e.g., altered
transcription factor expression, activation or motif specificity,
chromatin remodeling, or cellular environment). As with protein
coding sequence, gene regulatory sequences evolve as a conse-
quence of mutation and the subsequent action of genetic drift and
natural selection. Adaptive evolution is particularly prevalent in
immune response genes as a result of sustained selective pressure
exerted by rapid pathogen evolution (19–21).
In the present study, we developed a custom platform that
permits interspecies gene expression comparison and, in parallel,
performed genome-wide transcription start site (TSS) identifica-
tion by deeply sequencing mRNA 5′ ends on matched samples
from human and mouse. This study represents the most compre-
hensive and detailed study to date of a gene expression time
course, measured in parallel and anchored to experimentally de-
fined promoters, in two mammalian species. In so doing, we sys-
tematically identified conserved and divergent TLR4-regulated
gene expression, with demonstrated biological consequences, and
defined promoter properties that are associated with evolutionary
divergence in innate immune genes.
Results
LPS-Regulated mRNA Regulation in Human and Mouse Macrophages.
Interspecies comparisons that use whole-genome arrays exagger-
ate transcriptional divergence because of low transcript coverage
and poor internal replication. We therefore undertook a rigorous,
two-step approach. We first interrogated whole-genome micro-
arrays (Illumina; Affymetrix) to identify transcripts significantly
regulated over a time course of LPS stimulation in mouse or hu-
man macrophages. LPS-regulated genes identified in this screen
were then interrogated using custom-designed mouse and human
arrays. These afforded a high level of internal replication, com-
prehensive coverage of transcript variants, and superior probe
design to commercially available whole-genome arrays (Table S1).
We chose 2 h LPS stimulation as representative of direct re-
sponse genes (validated for the early response gene, TNF), 6 h as
representative of the peak of inflammatory gene responses, and
24 h to sample the subsequent “resolution” phase during which
feedback control is exerted (22, 23). To minimize differences
caused by cellular environment, we compared primary macro-
phage populations derived under very similar conditions ex vivo:
human monocyte-derived macrophages (HMDMs) and mouse
bone marrow-derived macrophages (BMMs). Both are differen-
tiated ex vivo with colony-stimulating factor (CSF)-1 for 7 d. We
also included a second mouse macrophage population, thiogly-
collate-elicited peritoneal macrophages (TEPMs), that are derived
frommouse monocytes in vivo and are commonly used as a cellular
model of inflammatory macrophages. Our choice of human and
mouse macrophages reflects the most widely used primary mac-
rophage populations in studies of innate immunity.
For one-to-one orthologues, we adopted a stringent approach
to capturing interspecies divergence by selecting a “representative
profile” for each gene (summarized in Fig. S1; see SI Glossary of
Technical Terms for definitions of all technical terms). This is
defined as the most similar expression profile between HMDM
and either mouse macrophage population, for any transcript (or
set of transcripts, wherein individual probes detect multiple tran-
scripts) emanating from that gene. Probe, transcript, and repre-
sentative profile data and statistical analyses are available from
the Macrophage Comparative Expression Gateway (MacGate,
http://www.macgate.qfab.org), and summary data are available in
Dataset S1A. Although our study focused on conservation and
divergence in LPS regulation between human and mouse genes
displaying one-to-one orthology relationships, we also analyzed
coregulation between genes with expanded orthology relation-
ships (e.g., one-to-many, many-to-many) and found regulatory
divergence between and within species was common, reflecting
the trend for paralogous genes to evolve specialized functions
(Fig. S2).
Conservation in LPS-Regulated Gene Expression in Human and Mouse
Macrophages. The relative importance of selection vs. random
genetic drift in shaping gene expression patterns is controversial
(24). Under a simple model of neutral drift, we would expect ex-
tensive gene expression divergence between species, approaching
saturation (24). In fact, gene regulation over the time course was
strikingly similar between the human (i.e., HMDM) and both
mouse (i.e., BMM, TEPM) macrophage populations (Fig. 1A).
Permutation testing of summed normalized expression difference
(SDiff, the sum of absolute differences between orthologous ex-
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Fig. 1. Global overview of LPS regulation between human and mouse
macrophage populations. Clustered representative profiles for (A) all one-to-
one orthologues significantly regulated by LPS in any macrophage pop-
ulation, (B) all profile-divergent orthologues, and (C) all time point-di-
vergent orthologues. Known examples of expression divergence between
the species were confirmed, including (D) INOS (P = 1.41 × 10−7), (E) IDO (P =
1.46 × 10−24), and (F) CYP27B1 (P = 2.31 × 10−7; microarray data average fold
induction ± SEM, n = 3–4, significance assessed by ANOVA). (G) Hierarchical
clustering of profile-divergent orthologues involved in immune defense or
antimicrobial pathways. Genes encoding cytokine, chemokine, and growth
factor ligands and receptors, as well as matrix metalloproteinases, were
subtracted from this list as they are considered separately in Fig. 3A. Gene
fold induction is indicated by the color-code key.















revealed that this similarity was significantly greater than would be
expected by chance (P < 0.05) for 30.30% (759 of 2,505) regulated
gene pairs. These results are consistent with the prevailing action
of purifying selection constraining regulatory divergence. The
overall similarities in the LPS-regulated mRNA expression pro-
files of the human and mouse macrophages support the view that
the experimental systems are broadly comparable and that the
transcription milieu triggered by LPS is also broadly conserved.
Identification of Interspecies Divergence Between Primary Human
and Mouse Macrophages. Given the overall conservation in LPS
responses, regulatory divergence should be viewed against a
background of overall similarity. By using the stringent approach
described earlier, representative profiles for 186 (7.4%) LPS-
regulated genes, whose profile in HMDM was significantly dif-
ferent (P < 0.05, two-way ANOVA with variables of sample and
time) to both mouse populations (i.e., BMM and TEPM), were
classified as differentially regulated across the LPS time course
(“profile divergent”; Fig. 1B and Fig. S1). To capture more
subtle differences in gene regulation between the species, we also
performed t tests to compare regulation at each time point
(“time-point divergent”; Fig. 1C). A total of 23.9% (598 of 2,505)
of regulated genes exhibited differential profile or time-point
regulation between human and both mouse macrophage pop-
ulations [“divergently regulated” (DR); Fig. S1 and Dataset
S1B]. As expected, our analysis captured TLR4 target genes al-
ready known to be differentially regulated between human and
mouse macrophages including INOS/NOS2 (Fig. 1D), IDO (Fig.
1E), and CYP27B1 (Fig. 1F). A number of genes known to be
involved in immune defense and antimicrobial pathways showed
profile divergence between species (Fig. 1G and Dataset S1C).
Macrophages exhibit a degree of plasticity with respect to phe-
notype and function. It was therefore conceivable that some of the
differences attributed to species divergence actually reflected het-
erogeneity between different macrophage populations. Our choice
of specific mouse macrophage populations was designed to mini-
mize such effects. CSF-1–replete BMMs are a proliferating cell
population, and LPS treatment causes growth inhibition. Conse-
quently, LPS regulates gene expression programs associated with
the cell cycle, as well as inflammatory and antimicrobial responses
in BMMs. TEPMs are post-proliferative, so LPS does not cause
growth inhibition in these cells. We therefore predicted over-
lapping but distinct LPS-regulated gene expression programs in
these cells. Indeed, BMMs and TEPMs did exhibit striking differ-
ences in LPS-regulated gene expression (Fig. S3), as we previously
documented for individual LPS target genes (26). Importantly, our
analysis required that theHMDMprofile was distinct from those of
both mouse macrophage populations. This selection criterion en-
abled us to identify a wide spectrum of LPS target genes in the
mouse, and to ensure that these genes were differentially regulated
in the primary human macrophage population examined.
To confirm that the aforementioned strategy had successfully
identified true species differences, we next tested expression of
individual human-specific TLR4 target genes by quantitative
PCR across an extensive panel of human and mouse primary
cells and cell lines that were not used in our initial expression
profiling analysis. The human-specific LPS target genes CCL20,
CXCL13, IL-7R, P2RX7, and STAT4 were all robustly up-regu-
lated in the human monocyte/macrophage populations examined
compared with the mouse macrophage populations (Fig. 2 A–E).
In each of these cases, the lack of induction by LPS in mouse is
supported by Cap-Analysis Gene Expression (CAGE) data from
the Functional Annotation of the Mouse (FANTOM) 3 project
(http://fantom3.gsc.riken.jp/) (27), as well as previous data with
the use of the Affymetrix array platform. Importantly, not all DR
genes showed an all-or-nothing response. Indeed, differences in
the timing or the magnitude of the response were frequently
observed (Fig. 1C and Fig. S1). In the case of the P2RX7 gene,
for example, rapid up-regulation was apparent in all human
myeloid populations (2 h after stimulation). In mouse cells, this
early response was not apparent, but up-regulation did occur for
some cell populations at a later time point (24 h after stimula-
tion; Fig. 2D). To further ensure that apparent species differ-
ences were not merely a result of differences in the cellular
systems used, we also sampled pig macrophages. In this species,
it is possible to generate both BMMs and monocyte-derived
macrophages (MDMs) in the presence of human CSF-1. LPS
robustly induced CCL20, CXCL13, and IL-7R in MDMs and
BMMs from pigs (Fig. 2 F–H). IDO and STAT4 were also LPS-
inducible in pig macrophages, whereas iNOS was not (28). Thus,
regardless of their origin (MDM or BMM), pig macrophages
resembled HMDMs rather than mouse BMMs or TEPMs in
their TLR4-regulated responses, thus confirming, at least for
these genes, that cell-type differences are not sufficient to ex-
plain the divergent regulation we observe.
Functional Impact of Regulatory Divergence in TLR4 Responses. We
next assessed the functional consequences of species differences
in TLR4 responses. A number of Gene Ontology terms were
significantly overrepresented in DR orthologues (Table S2),
many of which correspond to secreted or plasma membrane
proteins (156 genes; Dataset S1D), including a number of matrix
metalloproteinases and cytokine, chemokine, and growth factor
ligands and receptors. Fig. 3A shows a heat map for profile di-
vergent orthologues within this subset of secreted or plasma
membrane proteins. Such DR orthologues include CCL20,




























































































Fig. 2. Validation of human-specific TLR4 target genes and confirmed
coregulation in porcine macrophages. LPS-regulated mRNA expression of
selected human-specific TLR4 target genes was quantified by quantitative
PCR in cells from human (HMDMs, primary CD14+ monocytes, PMA-differ-
entiated THP-1 macrophage-like cells) or mouse (BMMs, TEPMs, BMMs de-
rived from BALB/c mice, C57BL/6 BMMs primed overnight with IFN-γ, C57BL/6
splenocytes, macrophage-like cell line RAW264.7). Human-specific LPS-reg-
ulated gene expression is displayed for CCL20 (A), CXCL13 (B), IL-7R (C),
P2RX7 (D), and STAT4 (E). Quantitative PCR data represent average fold
induction ± range (BALB/c BMMs, n = 2) or ± SEM (n ≥ 3, all other profiles) of
measurements with independent samples. Microarray data are shown only
for HMDMs, BMMs, and TEPMs (dotted line, average fold induction ± SEM,
n = 3–4). Expression of CCL20 (F), CXCL13 (G), and IL-7R (H) were further
investigated by profiling LPS-dependent gene expression in MDMs and
BMMs derived from pigs; data represent average fold induction ± SEM of
measurements with three or four independently prepared samples.
















































Fig. 3. Functional consequences of regulatory divergence in macrophage inputs and outputs. (A) Hierarchical clustering of DR orthologues that encode
matrix metalloproteinases or cytokines, chemokines, and growth factors and their receptors. Gene fold induction is indicated by the color-code key. Human-
specific production of the DR secreted proteins, CCL20 (B and D) and CXCL13 (C and E) in response to 24 h LPS treatment (B and C) or 24 h S. Typhimurium
infection (D and E) was validated by ELISA. Data represent mean ± SD of technical replicates (n = 4, LPS-stimulated HMDMs or BMMs) or mean ± range of
technical replicates (n = 2, LPS-stimulated TEPMs and Salmonella-infected HMDMs and BMMs). Profiles are representative of two to four experiments with
independent cellular sources. (F) Cell-surface IL-7Rα/CD127 expression on HMDMs and BMMs over a time course of LPS stimulation was measured by flow
cytometry [average mean fluorescence intensity (MFI) ± SD of n = 4 technical replicates, prepared, stimulated, and harvested in parallel]. Data are repre-
sentative of two to five experiments with independent cellular sources. (G) The reference Kyoto Encyclopedia of Genes and Genomes pathway for TLR
signaling was color-coded according to regulatory conservation (yellow) or divergence (profile or time point divergence; red) between species. LPS-regulated
orthologues displaying neither striking conservation nor divergence are shaded in gray, and genes that were not significantly LPS-regulated or not repre-
sented on the focused microarray are white. This striking separation of DR genes according to pathway input/output vs. pathway core is highly unlikely to
occur by chance (P = 4 × 10−7). (H) Macrophages were primed with LPS or medium for 11 h, washed, and restimulated with the TLR2/6 ligand FSL-1 for 8 h. IL-6
production was measured by ELISA. Data are average ± SD of three technical replicates, prepared, stimulated, and harvested in parallel, and are repre-
sentative of three or four independent experiments.















man-specific secretion of CCL20 and CXCL13 in response to
LPS (Fig. 3 B and C). Similarly, infection with the Gram-negative
pathogen Salmonella enterica serovar Typhimurium (S. Typhi-
murium) triggered CCL20 and CXCL13 production in human
but not mouse macrophages (Fig. 3 D and E). We also confirmed
induction of cell surface expression of the cytokine receptor IL-
7Rα (CD127) in HMDMs but not BMMs (Fig. 3F). In confir-
mation of the ontology enrichment analysis, annotation of the
core TLR signaling pathway itself according to regulatory di-
vergence highlights that signaling components were generally
conserved in their regulation, whereas regulatory divergence was
concentrated in cellular inputs and outputs (Fig. 3G). To ex-
amine potential regulatory divergence in TLR signaling and
TLRs themselves, we interrogated a broad, hand-curated set of
TLR-associated genes on the focused arrays. Twenty of these
were DR, including TLRs (e.g., TLR6, TLR8) and several neg-
ative feedback regulators (e.g., IRAK3, JDP2, SOCS1, and ATF3;
Fig. S4 A–D and Dataset S1E). The prevalence of regulatory
divergence in immune receptors suggests that LPS may differ-
entially affect sensitivity to a second immune challenge. In-
terspecies differences in ligand sensitization are likely to be
important in the context of infection or inflammation in which
multiple receptors are engaged. To verify this model, we selected
the pathogen recognition receptor TLR6 for functional analysis.
TLR6 mRNA was up-regulated by LPS in mouse but not human
macrophages (Fig. 3G and Fig. S4A; also see MacGate, http://
www.macgate.qfab.org). As predicted, LPS priming boosted IL-6
production in response to the TLR2/TLR6 agonist FSL-1 in
mouse macrophages, whereas this effect was not apparent in
human macrophages (Fig. 3H).
Species Divergence in Transcription Factor Gene Regulation. LPS
differentially regulated 49 transcriptional regulators between the
species (Fig. S4E and Dataset S1F). For example, HEY1 and
HESX1 were strikingly induced only in HMDMs (Fig. S4 F and
G). As with mRNA regulation (Fig. 2E), STAT4 protein was
markedly LPS-inducible in HMDMs and the human monocytic
cell line THP-1, but not in BMMs (Fig. S4H). Such data imply
that inducibly expressed, DR transcription factors may affect
downstream gene expression, thus contributing to regulatory
divergence. However, the extent of regulatory divergence be-
tween species declined with time when LPS-regulated genes
were partitioned according to the time point of their peak reg-
ulation (DR genes were 10.5% of total regulated genes peaking
at 2 h, 10.3% at 6 h, and 4% at 24 h after LPS stimulation; Fisher
exact test, P = 0.9101, P = 1.73 × 10−5, and P = 7.858 × 10−4,
respectively, for early/mid, mid/late, and early/late comparisons;
χ2 test, P = 1.27 × 10−4). This argues against inducible tran-
scription factors acting on downstream genes as a major driver of
regulatory divergence, although it is still possible that there is
some contribution from this mechanism. Contraction in in-
terspecies regulatory divergence across time could reflect dif-
fering mechanisms for feedback control of LPS-regulated gene
expression, which ultimately achieves the same end (Fig. S4 A–
C). It also suggests that evolution selects for the final LPS-in-
duced cellular state (e.g., 24 h and beyond) rather than the
specific mechanisms to achieve this state (2–6 h). Interestingly,
the kinetics of peak LPS regulation appeared to be more rapid in
HMDMs compared with mouse macrophages [502 human and
355 mouse profiles showed peak LPS regulation at the earliest
(2 h) time point; Fisher exact test, odds ratio of 1.52, P = 4.052 ×
10−8 for 2 h vs. not-2 h data partitions].
We also examined the time course of regulatory divergence
between the mouse macrophage populations. As these cells are
genetically identical, regulatory divergence must be mediated by
differences in the basal or inducible trans environment. In stark
contrast to the interspecies comparison, regulatory divergence
between the two mouse macrophage populations modestly in-
creased with time (1.27 and 1.65 fold for 2 h and 6 h vs. 24 h after
LPS stimulation; Fisher exact test, P = 0.08576, P = 1.42 × 10−5,
and P = 0.1171, respectively, for early/mid, mid/late, and early/
late comparisons; χ2 test, P = 5.14 × 10−5). The distinct temporal
signature in inter- vs. intraspecies gene regulatory divergence
further argues against a major contribution from macrophage
heterogeneity in the species divergence signature. It also suggests
that differences in cis (i.e., DNA sequence changes near the DR
gene) and/or the trans environment (e.g., availability of specific
transcriptional regulators) are likely to make a substantial con-
tribution to interspecies regulatory divergence.
Paradox of Promoter Conservation and Expression Divergence. To
examine the contribution of promoter sequence evolution to reg-
ulatory divergence between species, we precisely defined TSSs
using genome-wide deep CAGE performed in parallel with ex-
pression profiling. This yielded 5.3 million human macrophage and
2.6 million mouse macrophage tags that define TSSs to single nu-
cleotide resolution (Fig. S5A andB; data available at http://fantom.
gsc.riken.jp/4/download/Supplemental_Materials/Schroder_et_al_
2012/). CAGE-defined TSSs were projected ontomultiple genome
sequence alignments of as many as nine placental mammals with
deeply sequenced genomes (Fig. S5C). Each gene was assigned
a primary TSS in each species, being the TSS with the most CAGE
tags over the LPS time course, after correcting for depth of library
coverage. We initially investigated the role of TSS switching in
expression divergence (i.e., the primary TSS for a gene in one
species is not orthologous to the primary TSS in the other species),
but found that the DR gene set was not significantly enriched for
genes showing evidence of TSS switching between species (odds
ratios of 1.12 and 1.33 for profile and time-point divergent genes,
respectively; Fisher test, P > 0.2 in both cases). Subsequent anal-
yses focused on the stringently filtered set of 1,210 TSSs that occur
in orthologous positions and represent the primary TSSs in human
and mouse.
As we hypothesized that cis-regulatory sequence evolution
would be a major driver of gene regulatory divergence, we ana-
lyzed sequence conservation in promoters of DR vs. non-DR
genes. Several approaches confirmed a very surprising finding:
promoters driving DR genes were demonstrably more conserved
than non-DR promoters. Relative to non-DR genes, DR gene
“TSS regions” (−5 kb to +5 kb) exhibited a greater fraction of
human:mouse-aligning nucleotides than those of non-DR genes
(Fig. 4 A and B). We next analyzed the extent of core promoter
sequence divergence between species. DR gene core promoter
substitution rates (Rcore, −200 to −1 nt relative to TSS; further
information is provided in SI Glossary of Technical Terms) were
lower than non-DR substitution rates (Kolmogorov–Smirnov
test, D = 0.18, P= 3.4 × 10−4; Table S3), and Rcore was negatively
correlated with expression divergence (Spearman correlation,
ρ = −0.15, P = 3.6 × 10−6). One possible explanation for this
finding was that DR genes are biased toward regions in the ge-
nome that are highly conserved. To address this possibility, we
quantified evolutionary constraint on a per-promoter basis, cor-
recting for the local neutral rate of evolution. We thus calculated
Rcore to the substitution rate in nearby interspersed repetitive
elements (Rire) to give ωcore (i.e., Rcore/Rire), a measure analogous
to protein coding sequence ω (i.e., Rsynonymous/Rnonsynonymous).
The ωcore significantly negatively correlated with regulatory di-
vergence (SDiff; Spearman ρ = −0.13, P = 5 × 10−6; Table S3),
and the promoters of DR genes were significantly biased to lower
values of ωcore (Table S3 and Fig. 4C). Thus, higher sequence
conservation is associated with increasing regulatory divergence,
even when the local substitution rate was accounted for. Even
at a wider (1 Mb) interval, DR genes were significantly enriched
for association with conserved noncoding regions (as defined in
ref. 29) relative to non-DR genes (one-tailed Wilcoxon test, P =
0.0038). Together, these data indicate that regulatory sequences
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of DR genes are under greater evolutionary constraint than those
associated with non-DR genes.
Despite the predominant trend for evolutionary constraint
within DR gene promoters, the small population of core pro-
moters with substitution rates significantly in excess of the neu-
tral substitution rate (ωcore >1, <5% FDR), indicative of positive
selection, were modestly enriched for DR genes (odds ratio =
1.4; Dataset S1G). Thus, for a small number of DR genes, pos-
itive selection on cis-regulatory sequences within the proximal
promoter is likely to drive gene regulatory divergence. Conversely,
a small population of non-DR genes also exhibited strong evidence
of positive selection, demonstrating that rapid promoter evolution
may not always lead to a measurable impact on gene expression, at
least in our restricted sampling of cells and conditions.
Regulatory Divergence Is Associated with Specific Promoter Archi-
tecture. DR genes exhibited lower substitution rates 20 to 35
bases upstream of the TSS, and a series of pronounced peaks and
troughs in sequence conservation downstream of the TSS (Fig.
4), which are hallmarks of TATA box-containing promoters
(30). Indeed, promoters of DR genes were enriched for the
presence of a TATA box. 17.2% of human and 14.8% of mouse
DR gene promoters contained a TATA box, compared with
9.1% of human and 7.7% of mouse nondivergent gene pro-
moters (Fisher test, P= 1.2 × 10−7 and P= 4.8 × 10−7 for human
and mouse comparisons, respectively). To identify other features
of DR genes, we also surveyed transcription factor binding sites
(TFBSs) within proximal promoters. No position constraint was
applied in this analysis, as recent evidence suggests that func-
tional TFBSs are often not conserved across species (31). Al-
though our approach identified TFBSs in DR and concordantly
regulated genes that are commonly associated with LPS-regu-
lated transcription (e.g., Rel, Stat, Ets), we did not find any
strong association between specific TFBSs and regulatory di-
vergence (Table S4). As described earlier, the one obvious ex-
ception was the TATA motif, which was more likely to be
present in DR genes (odds ratio, 1.42; P = 3.32 × 10−3; Table
S4). However, even when using this approach that applied no
position constraint, the TATA box was present in fewer than
50% of DR genes. Thus, not all DR genes contain a TATA box
in their promoter regions.
Profile divergent genes (Fisher test, P = 2.67 × 10−7 and P =
9.69 × 10−10 for human and mouse comparisons, respectively)
and time point-divergent genes (Fisher test, P = 4.58 × 10−7 and
P = 1.39 × 10−7 for human and mouse comparisons, re-
spectively) were also significantly depleted of 5′ CpG islands,
compared with nondivergent genes. TATA enrichment and CpG
island depletion were not only associated with the degree of
regulatory divergence (ranking by SDiff or ANOVA P value),
but also the extent to which gene expression changes over the
LPS time course (dynamic range, calculated as the difference
between maximum fold induction and maximum fold suppres-
sion over the time course; Fig. 5 A and B). Conversely, genes
exhibiting a relatively small dynamic range and low interspecies
divergence were enriched for CpG island promoters and de-
pleted of TATA promoters. TATA enrichment and CpG island
depletion are clearly not redundant signals, as conditioning on
one does not remove the effect of the other (Fig. 5 C and D). A
gene’s dynamic range, as well as its maximum LPS-dependent
regulation (i.e., induction or suppression from unstimulated),
was clearly associated with regulatory divergence, such that
highly regulated genes were enriched for regulatory divergence
(Fig. 5 E and F). In total, these results indicate that TATA-
containing and non-CpG island promoters confer a high degree
of inherent transcriptional plasticity (i.e., the capacity of a gene
to change its transcription level under different environmental or
evolutionary conditions), as TATA-containing and non-CpG
island promoters were associated with both a large magnitude of
response to LPS and expression divergence between species.
TATA boxes tend to be associated with slowly evolving promoter
sequences, and CpG islands with rapidly evolving promoter
sequences (30), so it is important to note that the greater sequence
constraint observed in DR gene promoters (Table S3) held true
even within a promoter class (Fig. 4C). Thus, the effects observed
are not just a manifestation of differences in promoter architecture
between DR and non-DR genes, but rather are a general property
of DR macrophage gene promoters. These distinct properties ul-
timately validate our approach for identifying DR genes.
Discussion
Some differences between mouse and human LPS responses at
the whole-organism level are already documented (9). In this
study, we demonstrate differential gene regulation in response to
LPS in human and mouse macrophages that is strongly biased
toward genes encoding cell surface receptors and secreted mol-
ecules. Individual examples of such DR genes were further ex-
amined in porcine BMMs and MDMs, in which LPS profiles for
both macrophage populations reflected human-specific up-reg-
ulation, tempting speculation that the short generation time of
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Fig. 4. The promoters of DR genes exhibit a higher fraction of aligning
sequence and lower substitution rates than non-DR promoters. (A and B)
Spatial profile of human/mouse aligning sequence. The fraction of human
TSS region nucleotides aligned with mouse (A) and mouse TSS aligned with
human (B) for profile-divergent genes (red) vs. non–profile-divergent subset
(black), for which an orthologous macrophage TSS was defined in the other
species (mouse or human) by CAGE. (C) Distributions of core promoter cor-
rected substitution rate ratios [log10(ωcore)] for primary TSSs that are
orthologous between human and mouse (n = 1,190). log10(ωcore) < 0 indi-
cates predominantly purifying selection; log10(ωcore) > 0 indicates pre-
dominantly diversifying selection. Also shown is the distribution median
(vertical black/red bar), the fraction of all TSSs represented by the distribu-
tion (red to black fraction of vertical bar), and the median of all TSSs (pale
red). Distributions are shown for specific promoter types (TATA, CpG island,
neither TATA nor CpG island).















mice may accelerate regulatory evolution in this species. The
prevalence of regulatory divergence in cell surface and secreted
proteins predicts that differences in LPS regulation underpin
divergent cellular and physiological functional responses to LPS,
or may function to sensitize the cell to further stimuli that would
be present during in vivo inflammation. We verified this at the
cellular level by examining downstream responses to one DR
“input,” TLR6 (Fig. 3H). Notably, more than 150 other genes
encoding inputs and outputs were also differentially regulated,
which suggest further differences in macrophage functional re-
sponses to inflammation/infection in humans and mice, and/or
the mechanisms used to achieve them.
Although it is known that humans are physiologically more
sensitive than mice to LPS (9), the contribution of particular DR
genes to this phenomenon remains to be established. Our study
used a maximal stimulatory dose of LPS to elicit all LPS-regu-
lated transcriptional responses; thus, our data do not yield a di-
rect comparison of LPS sensitivity between human and mouse
macrophages. However, our data are suggestive of mechanisms
contributing to differential LPS sensitivity between species. We
observed more rapid peak regulation kinetics in human vs.
mouse macrophages, suggesting that HMDMs may be somewhat
“primed” for immediate/early LPS responses, which in turn
suggests increased sensitivity. We also observed more rapid and
greater induction of several negative feedback regulators of the
TLR pathway in mouse macrophages (IRAK3/IRAK-M and
JDP2; Fig. S4 B and C). Enhanced feedback regulation may
dampen the primary LPS response in mouse macrophages,
thereby contributing to the relatively reduced endotoxin sensi-
tivity observed in mice compared with humans. Elevated ex-
pression of some of the “human-specific” TLR4 target genes, for
example IL-7R (32) and CXCL13 (33), has been linked to
pathological human macrophage inflammatory responses. Simi-
larly, the chemokine CCL20, which was specifically induced in
human macrophages by LPS or whole pathogen infection in our
study, is clearly linked to a range of human autoimmune diseases
by virtue of its ability to attract pathogenic Th17 cells to a site of
in vivo inflammation (34). Furthermore, polymorphisms in sev-
eral DR genes, including coding sequence variants in P2RX7 (35)
and a promoter polymorphism in IL7R (36), have been associ-
ated with infectious and inflammatory diseases. Such data sup-
port the contention that DR genes are critical components of the
human innate immune system, and are likely to contribute to
pathological inflammatory processes.
Although some differences between species in antimicrobial
gene regulation have previously been documented, it is clear from
our study that multiple genes within such pathways were coregu-
lated in a species-specific fashion. For example,mouse-specific LPS
induction of Inos (Fig. 1D) paralleled that of mRNAs encoding
proteins regulating iNOS function (the arginine transporter Slc7a2
and the degradative enzyme arginase; also see MacGate, http://
www.macgate.qfab.org). Conversely, IDO and KYNU, which enc-
odes an enzyme downstream of IDO in the tryptophan metabolic
pathway, were coinduced in a human-specific manner (Fig. 1E;
also see MacGate, http://www.macgate.qfab.org). Importantly, our
approach also identified previously unrecognized regulatory di-
vergence in other antimicrobial pathways, such as Lcn2 (mouse-
specific) that encodes a secreted protein interfering with iron ac-
quisition by bacterial siderophores (37), and two genes specifically
induced in human macrophages (P2X7 receptor, P2RX7, and
CXCL13, Fig. 2 B and E) that are required for effective clearance
ofMycobacterium tuberculosis (38, 39). Given the evolutionary arms
race between host and pathogen, we postulate that many other DR
genes are likely to have key roles in direct antimicrobial responses
of macrophages.
Despite significant divergence in gene expression profiles,
LPS-regulated gene expression in human and mouse macro-
phages was far more similar than would be expected if expression
diverges randomly by neutral drift alone. This is consistent with
prior expectation and previous studies on other systems sug-
gesting that gene regulation is often conserved by purifying se-
lection (13, 18, 40, 41). Furthermore, expression divergence
declined over time, suggesting that, even in the face of extensive
species differences at early time points, the two biological sys-
tems ultimately reached a level of commonality, at least at the
cellular level. This in turn suggests that evolution selects for the
final LPS-reprogrammed cellular state (at 24 h and beyond)
rather than the means to achieve this state. Thus, robustness in
innate immune pathways may ultimately enable a level of func-
tional conservation in at least some biological responses.
Recent expression quantitative trait locus studies have high-
lighted the importance of cis-regulatory changes, and particularly
SDiff
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Fig. 5. DR genes are enriched for TATA box promoters, are depleted of CpG
islands, and tend to exhibit a large dynamic range of expression in response
to LPS. (A and B) Orthologous genes were ranked based on variation between
species (SDiff or P value for significance of profile divergence; high rank is
high significance and low P value) or dynamic range, such that genes with
a high variation within or between species achieve a high rank, and analyzed
according to percentage of genes with (A) CpG island-type orthologous gene
promoters or (B) TATA box-containing orthologous gene promoters. (C and
D) analyses were performed as in A and B, but considering only orthologues
without a TATA box in the promoter (C) or only those that had CpG island-
containing promoters (D). (E and F) Genes were ranked based on dynamic
range, maximum fold suppression, or maximum fold induction and analyzed
for percentage of DR genes according to (E) profile divergence or (F) time-
point divergence. For A–F, 100 randomly permuted rankings of the data are
shown (gray curves; nonrandom rankings protruding from the gray curves
represent P< 0.01). Also indicated are confidence intervals (95%, dashed gray
lines; 99%, dotted gray lines) and average for the whole dataset (solid gray
lines). Sliding 300-gene windows are shown.
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promoter region polymorphisms, in determining gene expression
level within the human population (42, 43). The strongest ex-
pression quantitative trait locus effects are preferentially clus-
tered around gene TSSs. We thus hypothesized that gene
expression divergence would be mirrored to some extent by se-
quence divergence in cis-regulatory sequences, particularly in
core promoters. Indeed, numerous promoter polymorphisms have
been identified that alter the expression of inflammation-
associated TLR4 target genes (e.g., IL1, IL6, TNF, IL10) (44).
This was indeed the case for a small number of DR genes, which
exhibited significantly faster than neutral substitution rates in
their promoters. These genes appear to possess very rapidly
evolving promoters, suggestive of sustained or repeated rounds
of diversifying selection. Notable among them is DDX58,
encoding the protein RIG-I, an RNA helicase that recognizes
viral RNAs and is a key regulator of antiviral innate immunity
(45). However, we consistently found the opposite of the
expected trend in the data set as a whole; interspecies regulatory
divergence was associated with constraint in promoter sequences.
This was seen in the per-promoter substitution rates (including the
ω estimates that correct for local background effects), the fraction
of nucleotides aligning between species, and the association of
highly conserved proximal noncoding regions with DR genes.
DR genes are significantly enriched for TATA-containing
promoters. Such promoters are known to possess a higher den-
sity of regulatory motifs relative to other promoters (46). This
likely explains the observation that such promoters evolve rap-
idly in their transcriptional regulation (14), despite their pro-
pensity for enhanced conservation at the nucleotide level. The
higher levels of promoter constraint we observed for DR relative
to non-DR genes also applied across promoter “categories”; DR
genes with TATA promoters have more constrained promoter
regions than non-DR genes with TATA promoters, and DR
genes have more constrained cis-regulatory sequences for the
CpG island promoter and non-CpG island promoter data par-
titions (Fig. 4C). Although enhanced promoter sequence con-
servation seems to be a generalized feature of DR genes, it is
important to note that not all DR genes are characterized by the
presence of a TATA box and/or lack of CpG islands. Indeed,
when applying a position constraint on the motif, only 17.2% of
human and 14.8% of mouse DR genes contained a TATA box.
STAT4 and CCL20, for example, were both induced in a human-
specific fashion (Fig. 2 A and E), yet only the latter is a TATA-
containing promoter in human, pig, and mouse. In some cases,
differences in the actual TATA box may directly contribute to
expression divergence. The IL-7Rα promoter, for example, is
a TATA-containing promoter in human and pig, but not mouse,
which is consistent with its human/pig-specific induction by LPS.
Dynamic range was also strongly correlated to the extent of
regulatory divergence. The most regulated genes in each species
were among the least likely to be similarly regulated in the other.
A large dynamic range in mRNA expression in response to
a TLR agonist indicates a gene is highly sensitive to changes in
the trans-regulatory environment. It follows, then, that such
genes might also be sensitive to the many alterations to the trans
environment concomitant with species divergence, consistent
with previous studies in yeast (14, 17, 46). Our data support such
a model for higher eukaryotes, and we extend this model by
showing the connection between greater transcriptional plasticity
(i.e., highly dynamic, evolvable transcriptional responses) and
higher levels of promoter constraint. Consider a promoter that
responds to multiple trans-regulatory inputs. The integration of
more inputs suggests more cis-regulatory sites, both in distant
enhancers and in the core promoter, where these signals are
ultimately assimilated for gene expression. A greater number of
cis-regulatory sites leads to a higher fraction of constrained sites
and promoter/cis-regulatory sequence conservation. Such a gene
is also likely to be hypersensitive to evolutionary perturbation of
the trans-acting milieu or specific cis-regulatory sites.
LPS induces transcriptional changes in hundreds of genes and
their products, indicative of complex gene regulatory networks
(22, 23, 47). Widespread divergence in TLR-regulated tran-
scription factor expression between mouse and human (Fig. S4
E–H) predicts species-specific transcriptional networks leading
to regulatory divergence. There are some correlative suggestions
of this from our analysis. For example, HEY1, which was spe-
cifically induced by LPS in human macrophages (Fig. S4F), was
recently identified as a negative feedback regulator of IL6 in
LPS-activated human macrophages (48). In our study, peak IL6
induction in HMDMs was significantly lower and faster than in
either BMMs or TEPMs (MacGate, http://www.macgate.qfab.
org), implicating this transcription factor in feedback regulation
in humans but not mice. Similarly, STAT4 was LPS-inducible in
human but not mouse macrophages (Fig. 2E and Fig. S4H), as
was the known STAT4 target gene, IRF4 (49) (MacGate, http://
www.macgate.qfab.org). Nonetheless, regulatory divergence sig-
nificantly contracted as the LPS time course proceeded. This
finding argues against a major input from inducible trans factors
to regulatory divergence, although we cannot discount the pos-
sibility that they make some contribution. Instead, we suggest
that different sets of LPS-inducible transcription factors in hu-
man vs. mouse enable conserved regulation of late response
genes and/or that DR inducible feedback regulators ultimately
limit functional divergence over time. It is also possible that
many of the TLR4-inducible transcription factors are not in-
volved in secondary LPS responses, but rather are induced to
permit responses to other stimuli in the in vivo setting. Impor-
tantly, the finding that divergence is most pronounced in primary
LPS responses suggests changes in cis and/or the basal trans
environment are the major drivers of regulatory divergence. We
have provided evidence for the former, but it is likely that the
latter also contributes.
In summary, we have performed the most stringent human:
mouse comparison of innate immune gene regulation reported
to date to the best of our knowledge. Many LPS-responsive
genes in mouse and human macrophages are conserved in their
regulation, but we also identified and validated considerable
divergence in TLR4 responses between these species. We sug-
gest this regulatory divergence is likely to be one contributing
factor to phenotypic differences between species in innate im-
munity. Importantly, our findings show that transcriptional
plasticity in response to a stimulus within species and variability
between species are intrinsically linked. The capacity for ex-
pression variation in both cases is associated with specific pro-
moter properties (high promoter conservation, TATA box
enrichment, and CpG island depletion). Paradoxically, differ-
ences in transcriptional regulation between species may be taken
as evidence that the absolute level of the transcript, and its
protein product, is crucial for innate immunity. By extension,
functional analyses of TLR4 target genes uniquely regulated in
human macrophages are likely to provide important insights into
human infectious and inflammatory diseases. Furthermore, by
revealing control points not already used in humans, the alter-
native evolutionary path trodden by the mouse may also provide
opportunities for therapeutic intervention in such diseases.
Materials and Methods
A summary of the methods used is presented in the subsequent sections;
further details are provided in SI Materials and Methods.
Ethics Statement. Before undertaking the studies described, approvals for all
experiments using primary human and mouse cells were obtained from the
relevant University of Queensland Ethics Committee.















Preparation of Primary Macrophages. HMDMs were differentiated in vitro
from CD14+ monocytes isolated from peripheral blood mononuclear cells
using MACS technology (Miltenyi Biotech), and BMMs were derived from
bone marrow progenitors. HMDMs and BMMs were differentiated from
progenitors in complete media containing recombinant CSF-1 for 7 d. Mouse
TEPMs were harvested by PBS solution lavage 5 d after i.p. injection of thi-
oglycollate broth. All mice were C57BL/6 unless otherwise stated.
Design, Hybridization, and Signal Processing of Custom Microarrays. By using
in-house and public access microarrays, we identified LPS-regulated genes
in HMDMs, BMMs, or TEPMs. We then designed human and mouse custom
15,000 probe microarrays (Agilent Technologies) targeting genes regulated
by LPS in any of these macrophage populations, for which orthology could be
predicted with high confidence. RNA from three independent cell prepa-
rations (BMMs, TEPMs) or four independent biological replicates (HMDMs, in
which each replicate RNA was a pool of RNA from two independent blood
donors; n = 8 donors in total) was analyzed by microarray.
Custom Microarray Data Analysis. Processed signal intensities were quantile
normalized in R using the Affymetrix package in Bioconductor, and median-
centered. Because of the high level of internal replication for the quantifi-
cation of transcript expression as a result of multiple probes targeting the
same transcript(s), probe-level data were collapsed into transcript-level data
if profiles from multiple probes were highly correlated. For one-to-one
orthologues, all transcript-level profiles significantly regulated by LPS were
compared with all transcript-level profiles for the orthologous gene. A two-
way ANOVA with two fixed effects (time and species) was fitted to nor-
malized, log10 data averaged over the replicates, and representative profiles
were chosen by taking the least divergent profile pair (highest Benjamini–
Hochberg corrected P value in either the HMDM/BMM or HMDM/TEPM
comparison). If this P value was below a threshold of 0.05, the orthologous
genes were classified as exhibiting significant profile divergence between
the species. A second statistical analysis was performed on the representa-
tive profiles for human and mouse to identify more subtle differences in
expression at single time points (more than threefold difference in expres-
sion and Student two-tailed t test P value <0.05). All P values for time point
or profile divergence calculated were corrected for multiple testing using
the Benjamini–Hochberg method. Expression profile similarity was further
assessed by using SDiff (25), calculated as the sum of absolute differences
between orthologous expression profile values over all time points. Con-
cordantly regulated genes were defined as those with SDiff scores lower
than 0.8 and lower than 0.6 (corresponding to P < 0.05 for randomly per-
muted data) for HMDM/BMM and HMDM/TEPM profile comparisons, re-
spectively. All microarray data (probe-level, transcript profile-level, and
representative human/mouse profiles) are freely available through MacGate
(http://www.macgate.qfab.org), and are also accessible via the National
Center for Biotechnology Information Gene Expression Omnibus repository
(GSE19492 SuperSeries containing human and mouse data for Agilent cus-
tom and Illumina whole-genome microarrays). Custom microarrays used in
this study are freely available for order from Agilent Technologies (probe
files available via GSE19492).
TSS Identification and Evolutionary Analyses. CAGE libraries from HMDM (0, 2,
6, 24 h LPS) and BMM (0, 6 h LPS) total RNA were prepared as described and
subjected to deep sequencing to identify TSSs (50). BMM deep CAGE data
were merged with comparable data from FANTOM3 for LPS-stimulated
BMMs (Fig. S5) (27). CAGE tags were mapped to genome assemblies (51)
(Hg18, Mm9) and mapped to probe sets via Ensembl and Refseq transcripts.
CAGE data are freely accessible through FANTOM (http://fantom.gsc.riken.jp/
4/download/Supplemental_Materials/Schroder_et_al_2012/). By this method,
at least one TSS was defined for 89% (2,238 of 2,505) of human and 92%
(2,297 of 2,505) ofmouse genes on the targetedmicroarray (Fig. S5). The EPO-
9 whole genome alignment dataset from Ensembl was used for coordinate
transformations between species to extract orthologous sequence align-
ments from the reference genomes for available eutherian mammals and for
the calculation of substitution rates.
TATA Box and CpG Island Mapping. CAGE-defined TSSs were defined as
“TATA-TSS” if they had a match to the Jaspar TATA box matrix (TFMscan,
options: −l, −p, 6), with the 5′ end of the match located 25 to 35 nt upstream
of the TSS reference position (the interval that shows TATA box enrichment
over the whole dataset). Genes were defined as “TATA-genes” if they had
one or more TATA-TSS. Mouse (mm9) and human (hg18) CpG islands were
downloaded from the University of California, Santa Cruz, genome table
browser, and CpG island genes were defined as those with a CpG island
overlapping their core promoter (−300 to +100 with respect to the TSS
reference position).
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